in 8 to 12 months the monthly sales figure should climb to $20,000,000 million plus, if xkem produces nicosan for a minimum of "only" 1,000,000 patience at that point. but there are an estimated 4 million patience in nigeria alone. then there are an estimated 14 to 17 million SCD sufferers world wide. the $18.- for children dosage and $24.- for adults is only meant for nigerias 4 million patience imo. the dosage price for export will be most likely be higher imo. i hope you all can figure out what that could mean in total sales eventually.......and what that could do to the shareprice. so why is everyone watching and worried about the s/p going $.0003 up or down? i see this as an unbelievable opportunity for all retail investors. all just my humble opinion. do your own DD. GLTA the LONGS, LT